相关实验视频

Updated: Jan 11, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

卵巢癌细胞中的SOAT1调节由CD8⁺ T细胞介导的免疫反应

Jiangnan He^1,2, Michelle K Y Siu¹, Runying Long^1,2

¹Departments of Obstetrics and Gynaecology, LKS Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong, Hong Kong, Special Administrative Region of China.

Journal of ovarian research

|November 19, 2025

概括

在卵巢癌细胞中醇-O乙烯转移酶1 (SOAT1) 抑制会通过增加免疫抑制性IL-6和IL-8增加CD8+T细胞免疫力,从而降低CD8+T细胞免疫力. 这表明SOAT1向可能对卵巢癌免疫疗法没有好处.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物化学生物化学

背景情况:

固醇-O乙烯转移酶1 (SOAT1) 将胆固醇转化为胆固醇,其抑制可以抑制瘤生长.
之前的研究表明,在T细胞中抑制SOAT1可增强CD8+T细胞的细胞毒性.
在卵巢癌的免疫微环境中SOAT1的作用需要进一步研究以优化免疫疗法.

研究的目的:

为了研究SOAT1在卵巢癌 (OC) 瘤免疫微环境中的作用.
评估SOAT1操纵和抑制对CD8+T细胞介导的免疫反应在OC体外的影响.
在卵巢癌中为联合免疫疗法策略提供信息.

主要方法:

使用GEPIA2进行相关性分析,以评估OC中的SOAT1表达和CD8+T细胞透.
基于SOAT1表达和CD8+T细胞透的GSE26712数据集的生存分析.
在体外实验中,在OC细胞中使用SOAT1敲除或aavasimibe治疗,以评估对CD8+T细胞细胞因子分泌的影响.

主要成果:

在OC中,SOAT1表达与细胞毒性CD8+T细胞透和效应体特征正相关.
高SOAT1表达与OC患者中CD8+T细胞的临床益处相关.
在OC细胞中SOAT1抑制 (敲击或阿瓦西米布) 降低了IFN-γ的分泌,并通过CD8+T细胞在体外对免疫抑制IL-6和IL-8进行了上调.

结论:

在卵巢癌细胞中抑制SOAT1可能会在体外损害CD8+T细胞的细胞毒性.
在SOAT1抑制的OC细胞中增加IL-6和IL-8的分泌可能会导致CD8+T细胞功能障碍.
在卵巢癌中准SOAT1可能不会增强,而是阻碍CD8+T细胞介导的抗瘤免疫力.

关键词:

CD8+ T 细胞的细胞.细胞毒性细胞毒性卵巢癌是发生在卵巢中的癌症.在SOAT1中,SOAT1是SOAT1,SOAT1是SOAT1.

更多相关视频

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...